Trastuzumab Emtansine Mixture from Japan
An immunological preparation mixing trastuzumab monoclonal antibody with emtansine, used for HER2-positive breast cancer treatment. It is in a mixed, non-retail bulk form, so it is classified under tariff item 3002.14.00.
Duty Rate — Japan → Canada
0%
Import Tips
• Confirm the product is not in measured doses or retail packaging to stay under this tariff item
• Keep records of the mixing process and antibody conjugate composition for CBSA verification
• Check if a clinical trial authorization or drug approval is needed from Health Canada